BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7788624)

  • 1. Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome.
    Yatham LN; Morehouse RL; Chisholm BT; Haase DA; MacDonald DD; Marrie TJ
    Can J Psychiatry; 1995 Mar; 40(2):93-6. PubMed ID: 7788624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome.
    Bearn J; Allain T; Coskeran P; Munro N; Butler J; McGregor A; Wessely S
    Biol Psychiatry; 1995 Feb; 37(4):245-52. PubMed ID: 7711161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
    Rajewska J; Rybakowski JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):705-9. PubMed ID: 12787860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment.
    Kasper S; Vieira A; Schmidt R; Richter P
    Pharmacopsychiatry; 1990 Mar; 23(2):76-84. PubMed ID: 2339181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V; Dinan TG
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ; Murray RM; O'Keane V
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
    Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
    Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.
    Thakore JH; Dinan TG
    Biol Psychiatry; 1995 Mar; 37(6):364-8. PubMed ID: 7772644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
    Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin and cortisol responses to fenfluramine challenge in mania.
    Yatham LN
    Biol Psychiatry; 1996 Feb; 39(4):285-8. PubMed ID: 8645775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic function in mothers of opioid addicts: correlation with comorbid depression.
    Gerra G; Caccavari R; Zaimovic A; Palladino M; Chittolini B; Giucastro G; Maestri D; Monica C; Fertonani-Affini G; Delsignore R; Brambilla F
    Acta Psychiatr Scand; 1997 Jul; 96(1):36-42. PubMed ID: 9259222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Endocrine responses to fenfluramine challenge in chronic fatigue syndrome.
    Cleare AJ; O'Keane V
    Can J Psychiatry; 1996 Mar; 41(2):129-31. PubMed ID: 8705960
    [No Abstract]   [Full Text] [Related]  

  • 14. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V; McLoughlin D; Dinan TG
    J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine responses in chronic schizophrenia. Evidence for serotonergic dysfunction.
    Lerer B; Ran A; Blacker M; Silver H; Weller MP; Drummer D; Ebstein B; Calev A
    Schizophr Res; 1988; 1(6):405-10. PubMed ID: 3154528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans.
    Monteleone P; Bortolotti F; Orazzo C; Serino I; Maj M
    Psychoneuroendocrinology; 1997 Feb; 22(2):79-87. PubMed ID: 9149330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.
    Cleare AJ; Bearn J; Allain T; McGregor A; Wessely S; Murray RM; O'Keane V
    J Affect Disord; 1995 Aug; 34(4):283-9. PubMed ID: 8550954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.
    Thakore JH; O'Keane V; Dinan TG
    Am J Psychiatry; 1996 Nov; 153(11):1460-3. PubMed ID: 8890681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
    Cleare AJ; Murray RM; O'Keane V
    Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.